---
title: "NBTX.US (NBTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NBTX.US/news.md"
symbol: "NBTX.US"
name: "NBTX.US"
parent: "https://longbridge.com/en/quote/NBTX.US.md"
datetime: "2026-05-21T08:46:09.550Z"
locales:
  - [en](https://longbridge.com/en/quote/NBTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NBTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NBTX.US/news.md)
---

# NBTX.US (NBTX.US) — Related News

### [Nanobiotix stock slides on $87M follow-on offering](https://longbridge.com/en/news/287183462.md)
*2026-05-21T08:33:18.000Z*
> Nanobiotix (NBTX) plans to raise approximately €75M ($87M) through a global follow-on offering, which includes a public 

### [Nanobiotix shares on Euronext Paris hit with temporary trading halt at company request](https://longbridge.com/en/news/287167972.md)
*2026-05-21T06:30:25.000Z*
> Nanobiotix has requested a temporary trading halt for its shares on Euronext Paris, effective from 9:00 a.m. CEST, to fi

### [Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris | NBTX Stock News](https://longbridge.com/en/news/287167937.md)
*2026-05-20T22:30:29.000Z*
> Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris | NBTX Stock News

### [Nanobiotix Announces Launch of Global Follow-On Offering | NBTX Stock News](https://longbridge.com/en/news/287126248.md)
*2026-05-20T14:20:34.000Z*
> Nanobiotix Announces Launch of Global Follow-On Offering | NBTX Stock News

### [How Nanobiotix Got Wall Street's Attention By Using Physics To Battle Cancer](https://longbridge.com/en/news/287076168.md)
*2026-05-20T13:17:38.000Z*
> Nanobiotix aims to revolutionize a long-standing cancer treatment method with innovative physics-based approaches. This 

### [Nanobiotix Reports Promising Phase 2 Data for NBTXR3 in Stage 3 Inoperable Lung Cancer](https://longbridge.com/en/news/286776980.md)
*2026-05-18T13:06:57.000Z*
> Nanobiotix reported promising Phase 2 data for its nanoradioenhancer NBTXR3 in treating stage 3 inoperable lung cancer. 

### [Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer | NBTX Stock News](https://longbridge.com/en/news/286675157.md)
*2026-05-17T06:15:25.000Z*
> Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) i